PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
News|Articles|January 19, 2021
Contec Introduces Sustainable Cleanroom Wipes
Author(s)Pharmaceutical Technology Editors
ReFIBE sterile cleanroom wipes are sustainable polyester wipes made from recycled post-consumer plastic bottles.
Advertisement
Contec announced on Jan. 19, 2020 that it has introduced ReFIBE sterile cleanroom wipes, sustainable polyester wipes made from recycled post-consumer plastic bottles.
According to a company press release, the plastic bottles are first chopped into flakes and cleaned, then the flakes are melted, filtered, and formed into chips, which are melted and made into yarn. Finally, the yarn is knitted into sterile and non-sterile 9” x 9” and 12” x 12” ReFIBE wipes.
Laser-cut with heat-sealed edges, ReFIBE are cleanroom laundered and made with 100% polyester, Contec said in the press release.
“ReFIBE has been such a fulfilling project to work on,” said Amy Russ, global project manager for the Cleanroom Division at Contec, in the press release. “We consider it our responsibility to offer clean, sustainable alternatives to our customers, and ReFIBE wipes are just the beginning. We are excited to develop more sustainable options for both existing Contec products and new innovations in the months and years to come.”
Source:
Advertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
What the Olanzapine Depot Approval Means for CMC Teams
3
Complying with International Pharmacopoeias
4
Q&A: Patient-Centric Drug Development Should Start at Product Definition
5